These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3568326)

  • 21. Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage.
    Abe T; Kazama M; Tahara C; Miura Y; Yasuda J
    Jpn J Med Sci Biol; 1977 Apr; 30(2):91-9. PubMed ID: 916354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
    Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
    Belousov IuB; Panchenko EP; Pivovarov VA; Nemiro VK
    Kardiologiia; 1979 Aug; 19(8):87-91. PubMed ID: 491364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
    Francis CW; Marder VJ
    J Clin Invest; 1987 Nov; 80(5):1459-65. PubMed ID: 3680507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-dimer antigen: current concepts and future prospects.
    Adam SS; Key NS; Greenberg CS
    Blood; 2009 Mar; 113(13):2878-87. PubMed ID: 19008457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clotting of mammalian fibrinogens by papain: a re-examination.
    Doolittle RF
    Biochemistry; 2014 Oct; 53(42):6687-94. PubMed ID: 25283163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A.
    Grøn B; Filion-Myklebust C; Bennick A; Nieuwenhuizen W; Matsueda GR; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):731-6. PubMed ID: 1489895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals.
    Pisano JJ; Bronzert TJ; Peyton MP; Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():98-113. PubMed ID: 4629559
    [No Abstract]   [Full Text] [Related]  

  • 39. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.
    Veklich Y; Ang EK; Lorand L; Weisel JW
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1438-42. PubMed ID: 9465033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.